Senti Biosciences Inc.
(SNTI)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -71.06M | -58.22M | -55.32M | -19.86M | -21.16M |
| Depreciation & Amortization | 5.24M | 3.92M | 3.01M | 1.99M | 1.40M |
| Stock-Based Compensation | 9.67M | 16.39M | 2.29M | 272.00K | 205.00K |
| Other Working Capital | 4.45M | 13.85M | 1.83M | 165.00K | - |
| Other Non-Cash Items | -916.00K | -10.89M | 14.74M | -5.03M | 1.38M |
| Deferred Income Tax | - | - | 22.00K | 235.00K | -329.00K |
| Change in Working Capital | 4.67M | 13.90M | 615.00K | -1.77M | 124.00K |
| Operating Cash Flow | -52.40M | -34.90M | -34.63M | -24.17M | -18.38M |
| Capital Expenditures | -12.04M | -41.37M | -5.54M | -1.16M | -2.00M |
| Acquisitions | 105.00K | - | - | -12.52M | - |
| Purchase of Investments | -17.99M | -40.59M | - | -446.00K | - |
| Sales Maturities Of Investments | 60.00M | - | - | 12.96M | - |
| Other Investing Acitivies | - | -40.59M | - | 12.52M | 5.75M |
| Investing Cash Flow | 30.08M | -81.96M | -5.54M | 11.36M | 3.75M |
| Debt Repayment | -108.00K | 5.17M | - | 8.00M | - |
| Common Stock Repurchased | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | 375.00K | 112.65M | 68.44M | 30.05M | 14.01M |
| Financial Cash Flow | 779.00K | 118.55M | 68.44M | 38.05M | 14.01M |
| Net Cash Flow | -21.54M | 1.70M | 28.26M | 25.24M | 5.80M |
| Free Cash Flow | -64.43M | -76.27M | -40.18M | -25.33M | -20.37M |